What question did this study set out to answer?

This study aims to assess the diagnostic value of systematic SARS-CoV-2 screening in identifying asymptomatic carriers.

April 10, 2026Open Access

Diagnostic Value and Outcomes of Systematic SARS-CoV-2 Screening in Asymptomatic Patients

Key Points

This study aims to assess the diagnostic value of systematic SARS-CoV-2 screening in identifying asymptomatic carriers.
Utilized a cohort study design.
Conducted universal screening for SARS-CoV-2 in asymptomatic individuals.
Aligned findings with community incidence of infection.
Detected asymptomatic carriers of SARS-CoV-2 infection.
Findings supported infection prevention and control measures.
Highlighted the need to consider unintended clinical outcomes during low incidence periods.

Abstract

In this cohort study, universal SARS-CoV-2 screening detected asymptomatic carriers of SARS-CoV-2 infection, aligned with community incidence, and thus may support infection prevention and control measures. However, the unintended clinical outcomes, particularly during times of low incidence, necessitate careful contextual implementation.

Diagnostic Value and Outcomes of Systematic SARS-CoV-2 Screening in Asymptomatic Patients

Key Points

Abstract

Cite This Study

Also Consider

Also Consider